# Antepartum Chronic Epidural Therapy (ACET) to Improve Blood Flow to the Uterus, Placenta and Baby in Pre-Eclampsia and Intrauterine Growth Restriction

> **NCT00197340** · PHASE3 · COMPLETED · sponsor: **Hadassah Medical Organization** · enrollment: 20 (estimated)

## Conditions studied

- Pre-Eclampsia
- Fetal Growth Retardation

## Interventions

- **DRUG:** Epidural ropivacaine

## Key facts

- **NCT ID:** NCT00197340
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2008-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00197340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00197340, "Antepartum Chronic Epidural Therapy (ACET) to Improve Blood Flow to the Uterus, Placenta and Baby in Pre-Eclampsia and Intrauterine Growth Restriction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00197340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*